PŘEVOD PRÁV Sample Clauses

PŘEVOD PRÁV. ZDRAVOTNICKÉ ZAŘÍZENÍ nesmí převést svá práva ani povinnosti dle této Smlouvy na třetí subjekt, bez předchozího písemného souhlasu CRO, která se zavazuje, že takový souhlas ZDRAVOTNICKÉMU ZAŘÍZENÍ bez závažného důvodu nebude odpírat. Jakýkoli neoprávněný pokus o převod práv a povinností ZDRAVOTNICKÉHO ZAŘÍZENÍ na třetí subjekt je neplatný a neúčinný. CRO má právo převést svá práva a povinnosti dle této Smlouvy na ZADAVATELE bez předchozího souhlasu ZDRAVOTNICKÉHO ZAŘÍZENÍ. Na důkaz souhlasu se zněním této Smlouvy, připojují její smluvní strany k Datu účinnosti Xxxxxxx své podpisy. INSTITUTION’S consent. In order to demonstrate their agreement, the parties have executed this Agreement as of the Effective Date. PAREXEL International Czech Republic s.r.o. By: Print Name: xxxx Title: Associate Director GRO,OSM Date: Fakultní nemocnice Královské Vinohrady By: PAREXEL International Czech Republic s.r.o. podpis: Jméno: xxxx Funkce: Associate Director GRO,OSM Datum: Fakultní nemocnice Královské Vinohrady podpis: Jméno: xxxxxxxxxxxxxx Funkce: náměstek pro vědu a akreditaci Datum: Print Name: xxxxxxxxxxxxxx Title: Date: Statement of investigator: I, xxxxx., the Principal Investigator of this Study, hereby acknowledge I have read the Protocol and all documents provided to me by CRO in order to perform this Study. I have read this agreement and I shall abide by the obligations of the Principal Investigator hereto, by the Act number 378/2007 Coll. on Pharmaceuticals, as amended and by other applicable legal regulations. I also undertake to ensure that all co-investigators and team members participating in performance of this Study, shall be properly notified of their rights and obligations with respect to this Agreement. I also acknowledge and warrant that, in compliance with a separate agreement between me and the Sponsor, from funds provided to me by the Sponsor, I shall pay the agreed fee to co-investigators and other persons participating in performance of this Study, for which I hereby accept a full responsibility. Date: Prohlášení zkoušejícího: Xx, xxxxx, hlavní zkoušející tohoto klinického hodnocení, tímto potvrzuji, že jsem se seznámil s protokolem a všemi dokumenty předanými CRO k provedení klinického hodnocení. Byl jsem seznámen s touto smlouvou, budu dodržovat povinnosti v ní stanovené hlavnímu zkoušejícímu a postupovat v souladu se zákonem č. 378/2007 Sb., o léčivech, v platném znění a dalšími právními předpisy. Současně potvrzuji, že zajistím, aby všichni ...
AutoNDA by SimpleDocs

Related to PŘEVOD PRÁV

  • Loop Provisioning Involving Integrated Digital Loop Carriers 2.6.1 Where InterGlobe has requested an Unbundled Loop and BellSouth uses IDLC systems to provide the local service to the End User and BellSouth has a suitable alternate facility available, BellSouth will make such alternative facilities available to InterGlobe. If a suitable alternative facility is not available, then to the extent it is technically feasible, BellSouth will implement one of the following alternative arrangements for InterGlobe (e.g. hairpinning):

  • FTTP Loop A Loop consisting entirely of fiber optic cable, whether dark or lit, that extends from the main distribution frame (or its equivalent) in an end user’s serving End Office to the demarcation point at the end user’s customer premises or to a serving area interface at which the fiber optic cable connects to copper or coaxial distribution facilities that extend to the end user's customer premises demarcation point, provided that all copper or coaxial distribution facilities extending from such serving area interface are not more than 500 feet from the demarcation point at the respective end users' customer premises; provided, however, that in the case of predominantly residential multiple dwelling units (MDUs), an FTTP Loop is a Loop consisting entirely of fiber optic cable, whether dark or lit, that extends from the main distribution frame (or its equivalent) in the End Office that serves the multiunit premises: (a) to or beyond the multiunit premises’ minimum point of entry (MPOE), as defined in 47 C.F.R. § 68.105; or

  • Designated Prescription Drug Prescribers and Pharmacies We may limit your selection of a pharmacy to a single pharmacy location and/or a single prescribing provider or practice. Those members subject to this designation include, but are not limited to, members that have a history of: • being prescribed prescription drugs by multiple providers; • having prescriptions drugs filled at multiple pharmacies; • being prescribed certain long acting opioids and other controlled substances, either in combination or separately, that suggests a need for monitoring due to: o quantities dispensed; o daily dosage range; or o the duration of therapy exceeds reasonable and established thresholds. The Amount You Pay for Prescription Drugs Our formulary includes a tiered copayment structure, which means the amount you pay for a prescription drug will vary by tier. See the Summary of Pharmacy Benefits for your copayment structure, benefit limits and the amount you pay. When you buy covered prescription drugs and diabetic equipment and supplies from a retail network pharmacy, you will be responsible for the copayment and deductible (if any) at the time of purchase. You will be responsible for paying the lower of your copayment, the retail cost of the drug, or the pharmacy allowance. Specialty prescription drugs are generally obtained from a specialty pharmacy. If you buy a specialty prescription drug from a retail network pharmacy, you will be responsible for a significantly higher out of pocket expense than if you bought the specialty drug from a specialty pharmacy. The amount you pay for the following prescription drugs is not subject to the tiered copayment structure: • Contraceptive methods; • Over-the-counter (OTC) preventive drugs; • Nicotine replacement therapy (NRT) and smoking cessation prescription drugs; • Infertility specialty prescription drugs; and • Covered diabetic equipment or supplies bought at a network pharmacy. See the Summary of Pharmacy Benefits for benefit limits and the amount you pay. This plan allows for medication synchronization in accordance with R.I. General Law

  • Vaccine Passports Pursuant to Texas Health and Safety Code, Section 161.0085(c), Contractor certifies that it does not require its customers to provide any documentation certifying the customer’s COVID-19 vaccination or post-transmission recovery on entry to, to gain access to, or to receive service from the Contractor’s business. Contractor acknowledges that such a vaccine or recovery requirement would make Contractor ineligible for a state-funded contract.

  • Target Population The Grantee shall ensure that diversion programs and services provided under this grant are designed to serve juvenile offenders who are at risk of commitment to Department.

  • Authorization Required Prior to Parallel Operation 2.2.1 The NYISO, in consultation with the Connecting Transmission Owner, shall use Reasonable Efforts to list applicable parallel Operating Requirements in Attachment 5 of this Agreement. Additionally, the NYISO, in consultation with the Connecting Transmission Owner, shall notify the Interconnection Customer of any changes to these requirements as soon as they are known. The NYISO and Connecting Transmission Owner shall make Reasonable Efforts to cooperate with the Interconnection Customer in meeting requirements necessary for the Interconnection Customer to commence parallel operations by the in-service date.

  • LICENCE FEE PARAMETERS 13.1 The Licensee must within 30 days of the last day of each Licence Year, for purposes of calculating the Licence Fee payable, provide SAMRO with a Licence Parameter Return ( available on the SAMRO website), indicating any and all changes to the licence parameters set out in this Agreement.

  • Local Switching Interfaces 4.2.13.1 Newcomm shall order ports and associated interfaces compatible with the services it wishes to provide as listed in Exhibit A. BellSouth shall provide the following local switching interfaces:

  • STATEWIDE CONTRACT MANAGEMENT SYSTEM If the maximum amount payable to Contractor under this Contract is $100,000 or greater, either on the Effective Date or at any time thereafter, this section shall apply. Contractor agrees to be governed by and comply with the provisions of §§00-000-000, 00-000-000, 00-000-000, and 00- 000-000, C.R.S. regarding the monitoring of vendor performance and the reporting of contract information in the State’s contract management system (“Contract Management System” or “CMS”). Contractor’s performance shall be subject to evaluation and review in accordance with the terms and conditions of this Contract, Colorado statutes governing CMS, and State Fiscal Rules and State Controller policies.

  • FORMAT AND CONTENT FOR REGISTRY OPERATOR MONTHLY REPORTING Registry Operator shall provide one set of monthly reports per gTLD, using the API described in draft-­‐xxxxxx-­‐icann-­‐registry-­‐interfaces, see Specification 2, Part A, Section 9, reference 5, with the following content. ICANN may request in the future that the reports be delivered by other means and using other formats. ICANN will use reasonable commercial efforts to preserve the confidentiality of the information reported until three (3) months after the end of the month to which the reports relate. Unless set forth in this Specification 3, any reference to a specific time refers to Coordinated Universal Time (UTC). Monthly reports shall consist of data that reflects the state of the registry at the end of the month (UTC).

Time is Money Join Law Insider Premium to draft better contracts faster.